Cargando…
Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer
The high mortality rate associated with castration-resistant prostate cancer (CRPC) underscores the need for improving therapeutic options for this patient population. The purpose of this study was to examine the potential of vascular targeting in prostate cancer. Experimental studies were carried o...
Autores principales: | Kalmuk, James, Folaron, Margaret, Buchinger, Julian, Pili, Roberto, Seshadri, Mukund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695192/ https://www.ncbi.nlm.nih.gov/pubmed/26203773 |
Ejemplares similares
-
Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
por: Bothwell, Katelyn D., et al.
Publicado: (2016) -
Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
por: Folaron, Margaret, et al.
Publicado: (2019) -
Multimodality Imaging of Abnormal Vascular Perfusion and Morphology in Preclinical 9L Gliosarcoma Model
por: Darpolor, Moses M., et al.
Publicado: (2011) -
Multimodality Imaging In Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles
por: Hwang, Jae Youn, et al.
Publicado: (2012) -
Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy
por: Pathmanathan, Angela U, et al.
Publicado: (2019)